The rate-limiting enzyme in the pentose phosphate pathway, glucose-6-phosphate dehydrogenase (G6PD), is an important mediator of adipose tissue inflammation and insulin resistance in subjects with obesity [66]. Here, G6PD is linked to obesity due to melanocortin 4 receptor deficiency.